What can biomarkers tell us about cognition in Parkinson's disease?
about
Quantitative EEG and Cognitive Decline in Parkinson's DiseaseBlood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease PatientsAn Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with DementiaLewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease DementiaDecrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.Unbiased approaches to biomarker discovery in neurodegenerative diseasesTherapeutic development paths for cognitive impairment in Parkinson's disease: report of a regulatory roundtableCerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease.Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's diseaseIncrease of EEG Spectral Theta Power Indicates Higher Risk of the Development of Severe Cognitive Decline in Parkinson's Disease after 3 Years.Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.Imaging the role of amyloid in PD dementia and dementia with Lewy bodies.Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.Oral biomarkers in exercise-induced neuroplasticity in Parkinson's disease.Introduction: the importance of cognition in movement disorders.Correlations between Motor Symptoms across Different Motor Tasks, Quantified via Random Forest Feature Classification in Parkinson's Disease.Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.Relationship between Apolipoprotein Superfamily and Parkinson's Disease.APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Skin biomarkers for neurodegenerative disease: a future perspective.Should post-mortem brain dissection be performed in Parkinson's disease with atypical dementia?A new biomarker for Parkinson's disease?Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson's Disease.Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program.Finding useful biomarkers for Parkinson's disease
P2860
Q26752409-84259B0F-6849-45E9-BE6F-15AF7FB4F837Q28550937-1B27D2CF-B9AC-48C6-85EB-2C65E9BEF293Q28552902-D528F2D8-C839-48CB-A83B-71BFA372D535Q33562458-375CB9C5-D364-41C2-A89C-CDC129549E98Q33574058-8AFB42F0-7FFE-4AF1-A64A-E664C448EDF4Q34625918-04EB627C-A541-43D7-B8B6-9CAF377E7884Q35211545-0307FBD0-9CEE-4704-A818-FFB5A7DFBA5DQ35772659-D8584C61-0431-40CD-8497-8A9DDBBDD0A6Q36276511-F96998E9-6E68-4107-84A2-51C8E5AF0DB0Q36343417-E5EDC409-8D1D-440C-A0E7-E52F30312B50Q37447122-831C5007-28DD-4CA9-ADE1-4180379EFCC8Q37494873-0BC8A75F-AA06-49C7-9965-C4927B288C7AQ38228098-D2B276C8-D34C-4ACE-BAB7-2B5B0558761BQ38416865-A45473D4-D7D0-46C6-B024-49C665D961B5Q38733922-998EA78F-46FA-45FE-84B1-33799332FE7BQ42110375-1E3C6F33-F3FC-4630-81A8-57751D8F7929Q45890380-31B3D619-3438-465A-B4EA-421AD2583378Q46255370-75E1D1B6-C5AA-4F5E-B86B-3E96D2E5DAD9Q47157982-08EADA89-DC17-4689-9077-661B51279321Q47571451-CDAAE5E3-84CD-4D44-944F-57797DD7EA0AQ48303426-CE900C1A-2FD9-4C14-B90F-5DF2C6501CE5Q48739544-C9A9C08B-E5E7-40EF-B3AB-6191C2BC7508Q49122011-3731DDF4-3800-4B05-B59B-32D1D239C385Q50584947-AFEC4DAC-4DFF-4C03-BC6D-F9556320DC26Q55257291-EF3FEF58-ED82-4C4C-948A-D8AD9BBEB0C2Q57971633-7A5200EA-AE57-4E33-BC31-29B499245E2E
P2860
What can biomarkers tell us about cognition in Parkinson's disease?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
What can biomarkers tell us about cognition in Parkinson's disease?
@en
type
label
What can biomarkers tell us about cognition in Parkinson's disease?
@en
prefLabel
What can biomarkers tell us about cognition in Parkinson's disease?
@en
P2860
P50
P356
P1433
P1476
What can biomarkers tell us about cognition in Parkinson's disease?
@en
P2093
Alice Chen-Plotkin
P2860
P304
P356
10.1002/MDS.25846
P407
P577
2014-04-01T00:00:00Z